C4 Therapeutics
CCCC
$6.74
Share price
4.82%
Change (1 day)
114.65%
Change (1 year)
Categories
Operating Margin for C4 Therapeutics (CCCC)
Operating Margin as of May 2024 (TTM): -474.39%
According to C4 Therapeutics's latest financial reports and stock price the company's current Operating Margin is -474.39%. At the end of 2021 the company had an Operating Margin of -183.23%.
Operating Margin history for C4 Therapeutics from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -183.23% | -9.17% |
| 2020 | -201.72% | 29.54% |
| 2019 | -155.72% | 91.93% |
| 2018 | -81.14% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.